Urte Gayko
Corporate Officer/Principal at SUMMIT THERAPEUTICS INC.
Profile
Urte Gayko is currently the Director & Head of Regulatory Affairs at Summit Therapeutics Ltd.
and the Chief Regulatory & Pharmacovigilance Officer at Summit Therapeutics, Inc. She previously worked as the Director of Regulatory Affairs at Amgen, Inc. from 1999 to 2008.
She also held positions as the Senior VP of Drug Development & Regulatory Affairs at Nektar Therapeutics, Vice President of Global Regulatory Affairs at Pharmacyclics LLC in 2012, and Vice President of Regulatory & Clinical Affairs at Nodality, Inc. from 2008 to 2012.
Dr. Gayko obtained a doctorate degree from Harvard University and completed her undergraduate and graduate studies at Freie Universität Berlin.
Urte Gayko active positions
| Companies | Position | Start |
|---|---|---|
| SUMMIT THERAPEUTICS INC. | Corporate Officer/Principal | 2023-10-15 |
Summit Therapeutics Ltd.
 Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Summit Therapeutics Ltd. operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom. | Director/Board Member | - |
Former positions of Urte Gayko
| Companies | Position | End |
|---|---|---|
| NEKTAR THERAPEUTICS | General Counsel | 2022-04-30 |
Nodality, Inc.
 Nodality, Inc. BiotechnologyHealth Technology Nodality, Inc. develops bioinformatics tools to enhance drug development process. Its technology profiles signaling networks in single cells by multiparametric phospho-flow cytometry. The company was founded by Michael C. Needels, Omar D. Perez, Garry P. Nolan and Rodney Weldon Turner in 2003 and is headquartered in San Francisco, CA. | Corporate Officer/Principal | 2011-12-31 |
| AMGEN INC. | General Counsel | 2007-12-31 |
| PHARMACYCLICS, INC. | General Counsel | - |
Training of Urte Gayko
| Harvard University | Doctorate Degree |
| Freie Universität Berlin | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| AMGEN INC. | Health Technology |
| NEKTAR THERAPEUTICS | Health Technology |
| SUMMIT THERAPEUTICS INC. | Health Technology |
| Private companies | 3 |
|---|---|
Pharmacyclics LLC
 Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Pharmacyclics LLC engages in developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. It has product candidates in clinical development and several preclinical molecules in optimization. The company was founded by Jonathan Sessler and Richard Miller in 1991 and is headquartered in Sunnyvale, CA. | Health Technology |
Summit Therapeutics Ltd.
Summit Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Summit Therapeutics Ltd. operates as a holding company, which engages in the discovery, development, and commercialization of antibiotic medicines. The company seeks to expand its product candidate portfolio through the development of new mechanism and precision antibiotics. Summit Therapeutics was founded by Stephen Graham Davies and Kay Dame Davies in January 2003 and is headquartered in Abingdon, the United Kingdom. | Health Technology |
Nodality, Inc.
Nodality, Inc. BiotechnologyHealth Technology Nodality, Inc. develops bioinformatics tools to enhance drug development process. Its technology profiles signaling networks in single cells by multiparametric phospho-flow cytometry. The company was founded by Michael C. Needels, Omar D. Perez, Garry P. Nolan and Rodney Weldon Turner in 2003 and is headquartered in San Francisco, CA. | Health Technology |
- Stock Market
- Insiders
- Urte Gayko
